Blue Crest Capital Management LTD Abb Vie Inc. Transaction History

Blue Crest Capital Management LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $287,171 - $323,422	-2,087 Reduced 16.71%	10,400 $1.61 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $1.21 Million - $1.4 Million	9,041 Added 262.36%	12,487 $1.86 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $456,629 - $568,245	3,446 New	3,446 $464,000
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $1.11 Million - $1.68 Million	-17,148 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $853,874 - $1.07 Million	11,838 Added 222.94%	17,148 $1.52 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $334,423 - $402,073	5,310 New	5,310 $402,000
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $1.52 Million - $1.95 Million	-23,200 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $1.79 Million - $2.11 Million	23,200 New	23,200 $1.87 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $1.95 Million - $2.41 Million	-25,075 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $3.37 Million - $3.75 Million	-37,926 Reduced 60.2%	25,075 $2.37 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $5.66 Million - $6.69 Million	63,001 New	63,001 $5.84 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $4.4 Million - $5.89 Million	-47,767 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $4.28 Million - $4.69 Million	47,767	47,767 $4.62 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.